## AMT: American Tower Corporation - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -3.8% below STRENGTH zone (3.0-6.0%); PEG 52.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($165.41)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Wedge Capital Management L L P NC Boosts Stock Holdings in American Tower Corporation $AMT**
- Source: MarketBeat | 20251222T125804 | Somewhat-Bullish | Relevance: 100%
- Wedge Capital Management L L P NC increased its stake in American Tower Corporation by 12.9% in Q3, now owning 59,832 shares valued at $11.51 million. American Tower exceeded Q3 earnings expectations, reporting EPS of $2.78 and revenue of $2.72 billion, and issued FY2025 EPS guidance of $10.60 to $10.72. The company also announced a quarterly dividend of $1.70 per share, representing an annualized yield of 3.9%, although it has a high payout ratio of 108.63%.

**2. Here's What Wall Street Thinks About American Tower Corporation (AMT)**
- Source: Finviz | 20251221T094500 | Bullish | Relevance: 100%
- Wells Fargo and UBS have reiterated "Buy" ratings for American Tower Corporation (AMT), with price targets of $200 and $260 respectively. Analysts believe AMT is well-positioned to benefit from increased carrier capacity needs and management is focused on strategic priorities like organic growth and capital allocation. The article notes AMT's position as a major REIT but suggests certain AI stocks might offer greater upside potential.

**3. Here’s What Wall Street Thinks About American Tower Corporation (AMT)**
- Source: Insider Monkey | 20251221T094500 | Bullish | Relevance: 100%
- Wall Street analysts, specifically from Wells Fargo and UBS, have reiterated "Buy" ratings for American Tower Corporation (NYSE: AMT). Analysts highlight the company's strategic priorities for accelerating organic growth, driving efficiencies, and disciplined capital allocation. They also foresee AMT benefiting from the projected doubling of carrier capacity over the next five years, despite ongoing litigation with Echostar.

**4. How Investors May Respond To American Tower (AMT) Pivot Toward CoreSite’s AI-Focused Data Center Expansion**
- Source: Simply Wall Street | 20251220T173030 | Neutral | Relevance: 100%
- American Tower (AMT) is shifting its focus to developed markets and expanding its CoreSite data center platform to capitalize on growing AI-related demand, a move supported by strong Q3 results in 2025. While this pivot could reshape its investment narrative, investors must consider risks like leverage, execution of data center expansion, and potential pullbacks in tenant spending, despite promising AI infrastructure growth. The article also highlights varied fair value estimates for AMT, suggesting diverse investor perspectives.

**5. Signal Advisors Wealth LLC Invests $8.07 Million in American Tower Corporation $AMT**
- Source: MarketBeat | 20251220T130930 | Somewhat-Bullish | Relevance: 100%
- Signal Advisors Wealth LLC initiated a new position in American Tower Corporation (NYSE: AMT) during the third quarter, acquiring 41,957 shares valued at approximately $8.07 million. American Tower exceeded Q3 earnings expectations and provided strong FY2025 guidance, alongside announcing a quarterly dividend. Institutional investors hold a significant portion of AMT, and recent insider transactions include a director's purchase and a major shareholder's substantial sale.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | RBC Capital | $220 | $220 | 0% |
| 2025-12-05 | Morgan Stanley | $225 | $235 | -4% |
| 2025-12-01 | Barclays | $200 | $203 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | RBC Capital | reit | Sector Perform |
| 2025-12-05 | Morgan Stanley | main | Overweight |
| 2025-12-01 | Barclays | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.99M) |
| Sells | 2 ($159.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (+1.0%)
- Blackrock Inc.: 9.7% (-0.6%)
- JPMORGAN CHASE & CO: 6.6% (+142.8%)
- State Street Corpora: 4.5% (-0.9%)
- Cohen & Steers Inc.: 2.9% (-2.9%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-4.7% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $160M sold (2 transactions in 90 days).
3. Valuation stretched: PEG 52.8x requires aggressive growth execution.
4. Long-term trend broken: trading 15.3% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 52.79 signals overvaluation risk, limited margin of safety. Forward P/E 24.8x attractive for 36% earnings growth. Quality metrics strong (ROE 29%, margin 28%). Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($159.6M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $80.8B |
| Beta | 0.92 |
| 52W Range | $170.87 - $234.33 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 52.79 |
| Forward P/E | 24.8 |
| Current P/E | 33.8 |
| YoY Growth | 36.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.9% to -3.8% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.8pp (needs >3.0% for momentum thesis). Below SMA200 (0.85x), long-term trend not supportive. MACD histogram bearish (-0.59), momentum weakening. OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.75% (CS: 7) | Weak |
| RSI_14 | 34.1 | Neutral |
| MACD Histogram | -0.59 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.949x | Below |
| vs SMA200 | 0.847x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $172.51
- **Stop Loss:** $165.41 (4.1% risk)
- **Target:** $179.61 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 84
- **Position Value:** $14,490.84
- **Portfolio %:** 14.49%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-24 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.65 | $1.82 | +10.1% |
| 2025Q2 | $1.66 | $0.78 | -53.0% |
| 2025Q1 | $1.57 | $1.04 | -33.7% |
| 2024Q4 | $1.98 | $2.62 | +32.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*